The effect of tiotropium bromide on health-related quality of life in chronic obstructive pulmonary disease

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Tiotropium bromide is a once-daily anticholinergic recommended for maintenance treatment of chronic obstructive pulmonary disease. The 24-h bronchodilation in patients with chronic obstructive pulmonary disease achieved with tiotropium treatment is currently unique. However, there is an increasing demand for proven efficacy in parameters of more direct interest to patients, in addition to physiological parameters. This article reviews the data currently available on the efficacy of tiotropium to improve the health-related quality of life of patients with chronic obstructive pulmonary disease.
Original languageEnglish
Pages (from-to)391-405
Number of pages15
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume6
Issue number4
DOIs
Publication statusPublished - 1 Aug 2006

Fingerprint

Chronic Obstructive Pulmonary Disease
Quality of Life
Cholinergic Antagonists
Therapeutics
Tiotropium Bromide

Cite this

@article{e9ec51e50fc54d5c835ebd186040576c,
title = "The effect of tiotropium bromide on health-related quality of life in chronic obstructive pulmonary disease",
abstract = "Tiotropium bromide is a once-daily anticholinergic recommended for maintenance treatment of chronic obstructive pulmonary disease. The 24-h bronchodilation in patients with chronic obstructive pulmonary disease achieved with tiotropium treatment is currently unique. However, there is an increasing demand for proven efficacy in parameters of more direct interest to patients, in addition to physiological parameters. This article reviews the data currently available on the efficacy of tiotropium to improve the health-related quality of life of patients with chronic obstructive pulmonary disease.",
author = "Price, {David Brendan}",
year = "2006",
month = "8",
day = "1",
doi = "10.1586/14737167.6.4.391",
language = "English",
volume = "6",
pages = "391--405",
journal = "Expert Review of Pharmacoeconomics & Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - The effect of tiotropium bromide on health-related quality of life in chronic obstructive pulmonary disease

AU - Price, David Brendan

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Tiotropium bromide is a once-daily anticholinergic recommended for maintenance treatment of chronic obstructive pulmonary disease. The 24-h bronchodilation in patients with chronic obstructive pulmonary disease achieved with tiotropium treatment is currently unique. However, there is an increasing demand for proven efficacy in parameters of more direct interest to patients, in addition to physiological parameters. This article reviews the data currently available on the efficacy of tiotropium to improve the health-related quality of life of patients with chronic obstructive pulmonary disease.

AB - Tiotropium bromide is a once-daily anticholinergic recommended for maintenance treatment of chronic obstructive pulmonary disease. The 24-h bronchodilation in patients with chronic obstructive pulmonary disease achieved with tiotropium treatment is currently unique. However, there is an increasing demand for proven efficacy in parameters of more direct interest to patients, in addition to physiological parameters. This article reviews the data currently available on the efficacy of tiotropium to improve the health-related quality of life of patients with chronic obstructive pulmonary disease.

U2 - 10.1586/14737167.6.4.391

DO - 10.1586/14737167.6.4.391

M3 - Article

C2 - 20528509

VL - 6

SP - 391

EP - 405

JO - Expert Review of Pharmacoeconomics & Outcomes Research

JF - Expert Review of Pharmacoeconomics & Outcomes Research

SN - 1473-7167

IS - 4

ER -